We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SPRO market cap is 61.48M. The company's latest EPS is USD -0.8758 and P/E is -1.34.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.99M | 2.01M | 47.44M | 2.07M | 2.72M |
| Operating Income | -26.08M | -11.83M | 25.92M | -14.23M | -12.89M |
| Net Income | -28.68M | -11.68M | 26.77M | -13.27M | -11.91M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.97M | 18.15M | 9.33M | 18.26M | 53.51M |
| Operating Income | -42.81M | -63.22M | -79.11M | -87.97M | -42.2M |
| Net Income | -41.66M | -60.93M | -78.28M | -89.76M | -46.42M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 63.63M | 64.48M | 124.8M | 112.55M | 98.89M |
| Total Liabilities | 27.71M | 31.99M | 48.87M | 47.71M | 44.1M |
| Total Equity | 35.92M | 32.48M | 75.93M | 64.84M | 54.78M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 129.01M | 106.1M | 153.45M | 171.07M | 124.8M |
| Total Liabilities | 13.15M | 31.53M | 21.41M | 82.78M | 48.87M |
| Total Equity | 115.86M | 74.57M | 132.04M | 88.29M | 75.93M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -51.26M | -52.21M | -7.73M | -12.85M | -31.42M |
| Investing | 33.94M | 33.81M | 33.81M | N/A | N/A |
| Financing | -49.86M | -43.73M | -29.55M | N/A | N/A |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -39.63M | -50.02M | -85.87M | -64.35M | -7.73M |
| Investing | -83.16M | 29.53M | 10.47M | 7.67M | 33.81M |
| Financing | 69.52M | 16.14M | 130.88M | 84.05M | -29.55M |
| Market Cap | 61.48M |
| Price to Earnings Ratio | -1.34 |
| Price to Sales Ratio | 1.16 |
| Price to Cash Ratio | 0.57 |
| Price to Book Ratio | 0.82 |
| Dividend Yield | - |
| Shares Outstanding | 53M |
| Average Volume (1 week) | 118.23k |
| Average Volume (1 Month) | 164.4k |
| 52 Week Change | -38.62% |
| 52 Week High | 2.04 |
| 52 Week Low | 0.99 |
| Spread (Intraday) | 0.15 (11.9%) |
| Company Name | Spero Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.sperotherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
